The efficacy of duvelisib monotherapy following disease progression on ofatumumab monotherapy in patients with relapsed/refractory CLL or SLL in the DUO crossover extension study

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 36; no. 15_suppl; p. 7533
Main Authors Kuss, Bryone J., Davids, Matthew Steven, Hillmen, Peter, Essell, James H., Moreno, Carol, Lamanna, Nicole, Nagy, Zsolt, Tam, Constantine Si Lun, Stilgenbauer, Stephan, Jäger, Ulrich, Ghia, Paolo, Delgado, Julio, Le, Ngocdiep T., Jeglinski, Brenda, Montillo, Marco
Format Journal Article
LanguageEnglish
Published 20.05.2018
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.7533